Skip to main content

Allogeneic Stem Cell Therapy in Heart Failure

  • Chapter
  • First Online:
Stem Cell Surgery Trials in Heart Failure and Diabetes
  • 172 Accesses

Abstract

The present aim is to perform a clinical double-blind, placebo-controlled Cardiology Stem Cell Center – Adipose Stem Cells (CSCC_ASC) study in heart failure patients to investigate the regenerative capacity of the CSCC_ASC treatment.

Cardiac Catheterization Laboratory 2014, The Heart Centre, University Hospital, Rigshospitalet, Copenhagen Ø, Denmark

Cardiac Catheterization Laboratory 2014, The Heart Centre, University Hospital, Rigshospitalet, Copenhagen Ø, Denmark

ClinicalTrials.gov Identifier: NCT03092284.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Weiss, J.N. (2022). Allogeneic Stem Cell Therapy in Heart Failure. In: Stem Cell Surgery Trials in Heart Failure and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-78010-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-78010-4_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-78009-8

  • Online ISBN: 978-3-030-78010-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics